Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Auguste, Peter ; Colquitt, Jill ; Connock, Martin ; Loveman, Emma ; Court, Rachel ; Ciccarelli, Olga ; Counsell, Carl ; Armoiry, Xavier
PharmacoEconomics, 2020-06, Vol.38 (6), p.527-536 [Periódico revisado por pares]Cham: Springer International Publishing
Texto completo disponível